Abstract

You have accessJournal of UrologyBenign Prostatic Hyperplasia: Surgical Therapy & New Technology IV (PD23)1 Sep 2021PD23-08 PREDICTORS OF 5-YEAR REOPERATION RATE AFTER TRANSURETHRAL RESECTION OF THE PROSTATE IN A DIVERSE, URBAN ACADEMIC CENTER Justin Loloi, Sarah Wang, Laura Douglass, Kara Watts, and Nitya Abraham Justin LoloiJustin Loloi More articles by this author , Sarah WangSarah Wang More articles by this author , Laura DouglassLaura Douglass More articles by this author , Kara WattsKara Watts More articles by this author , and Nitya AbrahamNitya Abraham More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000002016.08AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Benign prostatic hyperplasia (BPH) is one of the most common disorders in elderly men and one of the most common causes of lower urinary tract symptoms (LUTS). Transurethral resection of the prostate (TURP) remains the gold standard surgical intervention for treating symptomatic BPH that fails to respond to medical therapy. Nonetheless, long-term complications including reoperation occur in approximately 10% of procedures. We sought to evaluate predictors of reoperation after TURP in a diverse patient population. METHODS: A retrospective chart review was performed on all men who underwent TURP between 2013-2016 at our institution with follow-up data up to 5 years post-operatively. Variables collected included patient demographics and comorbidities, cystoscopy prior to TURP, prostate volume and prostate chips (in grams) resected. Primary outcomes included whether the patient underwent reoperation, months elapsed since TURP, and 5-alpha reductase use pre- and post-operatively. T-test and Chi-square or Fisher’s exact analyses were used to compare continuous and categorical variables respectively between those who underwent and did not undergo reoperation. RESULTS: 305 men underwent TURP during the study period (Table 1). Mean age was 68.9 ± 9.3. Non-Hispanic whites comprised 20.7% (n=63) of the study cohort, Non-Hispanic Blacks 28.9% (n=88), Hispanics 31.8% (n=97), and “Other” men 18.7% (n=57). Twenty four (8%) men underwent reoperation at a mean time of 23 months (range: 2 - 60 months). Reoperation after TURP was not associated with race, BMI, 5-alpha reductase use, pre-operative prostate volume, or weight of prostate chips resected. CONCLUSIONS: Reoperation after TURP occurred in 8% of our study cohort between two to sixty months after surgery. We did not identify significant predictors of reoperation. Larger scale studies are needed to identify risk factors for reoperation to improve patient selection for TURP and manage patient expectations accordingly. Source of Funding: None © 2021 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 206Issue Supplement 3September 2021Page: e423-e423 Advertisement Copyright & Permissions© 2021 by American Urological Association Education and Research, Inc.MetricsAuthor Information Justin Loloi More articles by this author Sarah Wang More articles by this author Laura Douglass More articles by this author Kara Watts More articles by this author Nitya Abraham More articles by this author Expand All Advertisement Loading ...

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.